Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Peter M Gordon

5PUBLICATIONS
7CO-AUTHORS
Biologically active moleculesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Nanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Mar 13, 2025
Single-Chain Nanobody Inhibition of Notch and Avidity Enhancement Utilizing the β-Pore-Forming Toxin Aerolysin.

Andrew C D Lemmex, Jeremy Allred, Jason Ostergard

|Dec 19, 2022
CXCR4 antagonists disrupt leukaemia-meningeal cell adhesion and attenuate chemoresistance.

Leslie M Jonart, Jason Ostergaard, Athena Brooks

|Jun 07, 2021
Preclinical efficacy of prexasertib in acute lymphoblastic leukemia.

Jason Ostergaard, Leslie M Jonart, Maryam Ebadi

|Aug 07, 2019
Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia.

Maryam Ebadi, Justin Wasko, Daniel J Weisdorf

|Feb 08, 2018
SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy.

Jordan A Naumann, John C Widen, Leslie A Jonart

Pageof 1

Frequent Collaborators

1 joint publications

Daniel A Harki

1 joint publications

Armin Rashidi

1 joint publications

Maryam Ebadi

1 joint publications

David J Gordon

1 joint publications

Michael J M Anderson

1 joint publications

Adam T Smiley

1 joint publications

Wendy R Gordon

Frequent Collaborators

1 joint publications

Daniel A Harki

1 joint publications

Armin Rashidi

1 joint publications

Maryam Ebadi

1 joint publications

David J Gordon

Top Related Videos

Selection of Transporter-Targeted Inhibitory Nanobodies by Solid-Supported-Membrane (SSM)-Based Electrophysiology
09:12

Selection of Transporter-Targeted Inhibitory Nanobodies by Solid-Supported-Membrane (SSM)-Based Electrophysiology

Published on : May 03, 2021

2.5K
A Kinetic Fluorescence-based Ca<sup>2+</sup> Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca<sup>2+</sup> Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on : Feb 20, 2018

9.0K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.3K
See more related videos

Top Related Videos

Selection of Transporter-Targeted Inhibitory Nanobodies by Solid-Supported-Membrane (SSM)-Based Electrophysiology
09:12

Selection of Transporter-Targeted Inhibitory Nanobodies by Solid-Supported-Membrane (SSM)-Based Electrophysiology

Published on : May 03, 2021

2.5K
A Kinetic Fluorescence-based Ca<sup>2+</sup> Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca<sup>2+</sup> Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on : Feb 20, 2018

9.0K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.3K
See more related videos